What it is
CJC-1295 without DAC is a short-acting GHRH analog; ipamorelin is a selective ghrelin-receptor agonist that triggers a growth-hormone pulse. A fixed blend combines the two signals in one draw. It cannot independently adjust the GHRH and secretagogue components.
Evidence boundary
Blend note only. The components have separate pharmacology, but the fixed-ratio blend does not have a validated titration.
Preparation and measurement
Reconstitution: 10 mg vial + 2 mL BAC = 5 mg/mL.
Concentration matches.
Reference schedule
| Phase | Dose | Draw / measure | Frequency | Weekly total |
|---|---|---|---|---|
| Weeks 1–2 | 100 mcg each (200 mcg total) | 2 units (0.02 mL) | 1x/day | 1.4 mg/week |
| Weeks 3–4 | 150 mcg each (300 mcg total) | 3 units (0.03 mL) | 1x/day | 2.1 mg/week |
| Weeks 5–6 | 200 mcg each (400 mcg total) | 4 units (0.04 mL) | 1x/day | 2.8 mg/week |
| Weeks 7–12 | 250–300 mcg each (500–600 mcg total) | 5–6 units (0.05–0.06 mL) | 1x/day | 4.2 mg/week |
Weeks 1–2
- Dose
- 100 mcg each (200 mcg total)
- Draw / measure
- 2 units (0.02 mL)
- Frequency
- 1x/day
- Weekly total
- 1.4 mg/week
Weeks 3–4
- Dose
- 150 mcg each (300 mcg total)
- Draw / measure
- 3 units (0.03 mL)
- Frequency
- 1x/day
- Weekly total
- 2.1 mg/week
Weeks 5–6
- Dose
- 200 mcg each (400 mcg total)
- Draw / measure
- 4 units (0.04 mL)
- Frequency
- 1x/day
- Weekly total
- 2.8 mg/week
Weeks 7–12
- Dose
- 250–300 mcg each (500–600 mcg total)
- Draw / measure
- 5–6 units (0.05–0.06 mL)
- Frequency
- 1x/day
- Weekly total
- 4.2 mg/week
Weekly totals apply only during the active phase.
Titration rules
-
Hold each listed step for the full interval before increasing.
-
Because the ratio is fixed, a 200 mcg increase in total blend raises each component by 100 mcg.
-
Do not add a separate secretagogue without calculating the combined ipamorelin exposure.
-
Water retention, tingling, headache, hunger, fasting glucose, and IGF-1 where monitored
-
Whether the blend is being treated as a finished standard
Practical rules
- Keep the food window consistent if someone is comparing notes.
- Record the total blend dose and the delivered dose of each component.
- Do not add another secretagogue without checking the total exposure.